Hologic

Reshaping Gynecologic Health

The Hologic GYN Surgical Solutions division offers a suite of minimally invasive treatment options that lead to maximum results.

Our solutions provide long-lasting relief for women facing gynecologic conditions that affect their uterine health and well-being. While science and technology drive our treatments, restoring women’s quality of life is our goal.

Hologic_logo

Brochures

hologic_novasure

NOVASURE

Nearly two decades of real-world experience, the NovaSure® Endometrial Ablation system has treated 3 million patients worldwide.  Abnormal uterine bleeding (AUB) can dramatically affect a woman’s comfort, confidence, and quality of life.  The NovaSure endometrial ablation procedure is a simple way to reduce, or stop, menstrual bleeding for women with AUB.

hologic_myosure

MYOSURE

The MyoSure® system provides a fast, convenient way to hysteroscopically remove intra-uterine pathology while maintaining uterine form and function.  Its 100% mechanical resection preserves tissue margins.  The MyoSure suite, provides a full spectrum of tissue removal device options whatever the size of the pathology.  MyoSure MANUAL, MyoSure LITE, MyoSure REACH, MyoSure XL.

hologic_omni

OMNI

Taking see and treat to the next level! The Omni hysteroscope® is 3 hysteroscopes in 1, providing convenience to see and treat pathology with a single hysteroscope.  The rod lens ensures quality visualisation throughout procedures and with its long working length of 200mm facilitates easier access and treatment for larger patients, together with a small outer diameter for ease of insertion and greater patient comfort.

hologic_fluent

FLUENT

Simplified procedures with greater control for hysteroscopy.  The Fluent® fluid management system is designed to transform how fluid management is experienced, with easy-to-use, advanced medical technology that can help facilities operate more efficiently.

7467_Holigic EGSE Web Banner_v11

Contact Hologic

  • This field is for validation purposes and should be left unchanged.